FDA Approval/Clearance
12.03.18
Ocular Therapeutix Announces FDA Approval of Dextenza for the Treatment of Ocular Pain Following Ophthalmic SurgerySource: Ocular Therapeutix
08.23.18
Kala Pharmaceuticals Announces FDA Approval of Inveltys for the Treatment of Postoperative Inflammation and PainSource: Kala Pharmaceuticals
08.23.18
Dompé Receives FDA Approval of Oxervate, the First Drug for Neurotrophic KeratitisSource: Dompé
06.25.18
Glaukos Announces FDA Approval for the iStent inject Trabecular Micro-Bypass SystemSource: Glaukos
06.18.18
Bausch + Lomb Receives FDA Premarket Approval for Envista Toric MX60T IOLSource: Bausch + Lomb
06.18.18
FDA Approves iDESIGN Refractive Studio Allowing for Customized LASIK TreatmentSource: Johnson & Johnson Vision